SHAREHOLDER ALERT: Aerovate Therapeutics Investigated for Securities Fraud Violations by Block & Leviton

Boston, MA

BOSTON, June 17, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Aerovate Therapeutics, Inc. (Nasdaq: AVTE) for potential securities law violations. Investors who have lost money in their Aerovate Therapeutics investment should contact the firm to learn more about how they might recover those losses. For more details, visit

What is this all about?

Shares of Aerovate Therapeutics are down 90.1% following the release of poor top line results from its Phase 2b portion of IMPAHCT evaluating AV-101 for the treatment of pulmonary arterial hypertension. Block & Leviton is investigating whether the Company violated any securities laws in the lead up to this announcement.

Who is eligible?

Anyone who purchased Aerovate Therapeutics common stock and has seen their shares fall may be eligible, whether or not they have sold their investment. Investors should contact Block & Leviton to learn more.

What is Block & Leviton doing?

Block & Leviton is investigating whether the Company committed securities law violations and may file an action to attempt to recover losses on behalf of investors who have lost money.

What should you do next?

If you've lost money on your investment, you should contact Block & Leviton to learn more via our case website, by email at, or by phone at (888) 256-2510.


If you have non-public information about Aerovate Therapeutics, you should consider assisting in our investigation or working with our attorneys to file a report with the Securities Exchange Commission under their whistleblower program. Whistleblowers who provide original information to the SEC may receive rewards of up to 30% of any successful recovery. For more information, contact Block & Leviton at or by phone at (888) 256-2510.

Why should you contact Block & Leviton?

Block & Leviton is widely regarded as one of the leading securities class action firms in the country. Our attorneys have recovered billions of dollars for defrauded investors and are dedicated to obtaining significant recoveries on behalf of our clients through active litigation in the federal courts across the country. Many of the nation's top institutional investors hire us to represent their interests. You can learn more about us at our website, call (888) 256-2510 or email with any questions.

This notice may constitute attorney advertising.

260 Franklin St., Suite 1860
Boston, MA 02110
Phone: (888) 256-2510